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HIGHLIGHTS
Obstructive and restrictive lung function abnormalities occur in SCD children
SCD children have increased pulmonary capillary blood volume (PCBV)
Respiratory system resistance and PCBV were measured before/after
transfusion
Respiratory system resistance and PCBV significantly increased post
transfusion
Increased PCBV may partially explain lung function abnormalities in SCD
children
*Highlights (for review)
ABSTRACT
Lung function abnormalities occur in children with sickle cell disease (SCD) and may be
associated with elevated pulmonary blood volume. To investigate that association, we
determined whether blood transfusion in SCD children acutely increased pulmonary capillary
blood volume (PCBV) and increased respiratory system resistance (Rrs5). Measurements of
Rrs5 and spirometry were made before and after blood transfusion in 18 children, median
age 14.2 (6.6 18.5) years. Diffusing capacity for carbon monoxide and nitric oxide were
assessed to calculate the PCBV. Post transfusion, the median Rrs5 had increased from
127.4 to 141.3% predicted (p < 0.0001) and pulmonary capillary blood volume from 39.7 to
64.1 ml/m2 (p < 0.0001); forced expiratory volume in one second (p=0.0056) and vital
capacity (p=0.0008) decreased. The increase in Rrs5 correlated with the increase in PCBV
(r=0.50, p=0.0493). Increased pulmonary capillary blood volume may at least partially
explain the lung function abnormalities in SCD children.
Key words:   Sickle cell disease, lung function abnormalities, pulmonary capillary blood
volume, transfusion
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ABSTRACT
Lung function abnormalities occur in children with sickle cell disease (SCD) and may be
associated with elevated pulmonary blood volume. To investigate that association, we
determined whether blood transfusion in SCD children acutely increased pulmonary capillary
blood volume (PCBV) and increased respiratory system resistance (Rrs5). Measurements of
Rrs5 and spirometry were made before and after blood transfusion in 18 children, median
age 14.2 (6.6 18.5) years. Diffusing capacity for carbon monoxide and nitric oxide were
assessed to calculate the PCBV. Post transfusion, the median Rrs5 had increased from
127.4 to 141.3% predicted (p < 0.0001) and pulmonary capillary blood volume from 39.7 to
64.1 ml/m2 (p < 0.0001); forced expiratory volume in one second (p=0.0056) and vital
capacity (p=0.0008) decreased. The increase in Rrs5 correlated with the increase in PCBV
(r=0.50, p=0.0493). Increased pulmonary capillary blood volume may at least partially
explain the lung function abnormalities in SCD children.
Key words: Sickle cell disease, lung function abnormalities, pulmonary capillary blood
volume, transfusion
1. INTRODUCTION
Sickle cell disease (SCD) is one of the commonest inherited disorders worldwide;
approximately 250,000 children are born with homozygous SCD per year (Piel et al 2013).
The majority of children with SCD in developed countries can expect to survive to adulthood
[Quinn et al 2010), but may then suffer severe pulmonary morbidity including hypoxia and
pulmonary hypertension (Powars et al 1988). Restrictive and obstructive lung function
abnormalities are common. Restrictive lung disease is associated with increasing age
(Sylvester et al. 2004, MacLean et al. 2008) and obstructive defects can occur even in young
children with SCD (Koumbourlis et al 2001, 1997). Hence, it is important to understand the
etiology of such abnormalities; mechanistic insights are necessary to better inform therapy to
hopefully prevent SCD pulmonary complications. A number of researchers have suggested
that asthma is responsible for impaired lung function and respiratory symptoms in SCD, but
the evidence is conflicting. A high prevalence of asthma in children with SCD has been
reported in one study (Knight-Madden et al 2005), but not in others (Bernaudin et al 2008,
Boyd et al 2004). In addition, the response to bronchial challenges in SCD patients, such as
cold air, exercise, or methacholine has been variable ranging from no response (Chaudry et
al 2014) to 78% of those tested having a positive response (Ozbek et al 2007).
Furthermore, whereas some studies have shown a high response rate to bronchodilator
therapy in SCD children compared to controls (Knight-Madden et al 2005, Koumbourlis et al
2001), others have shown no significant difference in the response rates of SCD children
compared to that of controls (Sylvester et al 2004).
An alternative explanation for the impaired lung function is increased pulmonary capillary
blood volume due to chronic anemia resulting in a raised cardiac output and increased
vascular recruitment and distension (Batra et al 2002, Chaudry et al 2011, Delclaux et al
2005, Femi-Pearse et al 1970, Lunt et al 2014, Wedderburn et al 2014). Indeed, we have
demonstrated children with SCD have increased pulmonary capillary blood volume
compared to controls, which was associated with airway obstruction and correlated with
respiratory system resistance (Wedderburn et al 2014).  Similarly in adults, vascular
changes on high resolution computed tomography (HRCT) (increased segmental pulmonary
artery diameter and total cross-sectional area of all pulmonary vessels less than 5mm in
diameter (CSA<5mm%), correlated with reductions in lung function (Lunt et al 2014).
Experimental increases in thoracic blood volume have been shown to produce reductions in
lung function and an increase in respiratory system resistance. For example, rapid saline
infusion has been shown to produce a significant decrease in dynamic lung volumes as
assessed by spirometry in healthy adults (Collins et al 1973, Muir et al 1975), as well as in
patients with left ventricular failure (Puri et al 1999). In addition, Lorino et al found that the
inflation of pneumatic trousers in healthy subjects caused an increase in respiratory system
resistance as assessed by impulse oscillometry (Lorino et al 1994). Recently Bihari et al
(2015) demonstrated that in healthy subjects, infusion of 0.9% saline caused a significant
increase in respiratory system resistance at 5Hz as assessed by impulse oscillometry. Such
studies have not been performed in SCD children, but some SCD children receive blood
transfusions as part of their routine care. Blood transfusions have been shown to result in
transient increases in cardiac output (Duke et al 1964). Routine blood transfusions in SCD
children would then allow investigation of the acute effect of fluid loading on lung function
and further add to the understanding of the etiology of pulmonary function impairment in
SCD children The aim, therefore, of this study was to test the hypothesis that blood
transfusion would result in an acute increases in pulmonary capillary blood volume and
respiratory system resistance and reductions in spirometry in children with SCD. Such data
would further aid the understanding of the pathophysiology of lung function abnormalities in
SCD children.
2. METHODS
Children homozygous for sickle cell haemoglobin (HbSS) undergoing regular blood
children of seven years of age or greater were recruited as they were likely to be able to
complete all the lung function
NHS Foundation Trust Research Ethics Committee and parents gave informed, written
consent for their child to take part. Impulse oscillometry, spirometry and pulmonary capillary
blood volume were measured before and immediately after transfusion. In order to further
characterise the lung function of the patients, static lung volumes were measured before
transfusion. The volume of packed red cells (PRCV) administered to each patient was
determined using the following formula: PRCV (mls) = patient weight (kg) * change in
haemoglobin to be achieved (g/dl) * transfusion factor of (4-5 ml.kg-1/g.dl-1), in order to
achieve a target haemoglobin concentration of 13.5g/dl. All transfusions were administered
over approximately four hours.
2.1 Lung function assessments
Spirometry, gas transfer for carbon monoxide and body plethysmography were performed.
The forced expiratory volume in one second (FEV1) vital capacity (VC), ratio of FEV1 to VC
(FEV1/VC), forced expiratory flow between 25 and 75% of VC (FEF25-75), transfer factor for
carbon monoxide (DLCO), transfer factor adjusted for alveolar volume (KCO), total lung
capacity (TLC), residual volume (RV) and the ratio of RV to TLC (RV:TLC) were assessed
according ATS/ERS guidelines. The highest forced vital capacity result obtained from
spirometry and the slow vital capacity from the DLCO manoeuvre were reported as VC.
Results were expressed as the percentage predicted for height using an ethnic-specific
reference range for spirometry and Caucasian reference data for gas transfer and body
plethysmography (Quanjer et al 2012, Rosenthal et al 1993).  Respiratory system resistance
(Rrs) was also measured using impulse oscillometry. Rrs was measured before the other
and proximal changes in lung function. Respiratory system resistance at 20Hz (Rrs20), the
frequency dependence of resistance (R5-R20), the respiratory system reactance at 5Hz
(Xrs5), the resonant frequency (fres) and the area under the reactance curve between
resonant frequency and 5Hz (AX) were also recorded. For all IOS indices the whole-breath
values were reported. All measurements were performed using a commercially available
lung function system (Jaeger MasterScreen IOS, Carefusion Ltd, Basingstoke UK).
The Rrs5, Rrs20, Xrs5, and fres results were expressed as the percent predicted for height
using the reference range of Nowoweijska et al (Nowowiejska et al 2008). Raw values were
reported for R5-R20 and AX as predicted values are not available for these indices for the
age range of the children studied. For IOS indices, the mean of two measurements for Rrs5
and Rrs20 were reported for each measurement the two results were within 5% of each
other.
Patients were diagnosed with an obstructive abnormality if their FEV1:FVC was less than the
lower limit of normal (LLN) (Pellegrino et al 2005), based on the ethnic specific reference
range of Quanjer et al. A restrictive abnormality was diagnosed if the TLC was below the
LLN (Pellegrino et al 2005) based on the reference range of Rosenthal et al
correction factor applied (Kirkby et al 2013). A mixed abnormality was diagnosed if the TLC
and FEV1/VC were less than the LLNs (Pellegrino et al 2005).
2.2 Pulmonary capillary blood volume
Pulmonary capillary blood volume was measured using the single breath-hold method for
gas transfer for carbon monoxide (DLCO) and nitric oxide (DLNO) using a commercially
available system (Jaeger MasterScreen PFT Pro, Carefusion Ltd, Basingstoke UK)
Pulmonary membrane diffusing capacity (DMCO) and pulmonary capillary blood volume
(PCBV) were determined using the Roughton-Forster model as previously described
(Wedderburn et al 201
using the formula of Mosteller et al (Mosteller 1987).   The mean of two measurements
within 5% was reported. Baseline DLCO results corrected for the haemoglobin concentration
[Hb] from a blood test taken immediately before transfusion were also recorded.
3. Sample size
18 children studied pre- and post-transfusion allowed detection of differences before and
after transfusion equivalent to one standard deviation of the results of each measurement
technique with 80% power at the 5% level.
4. Analysis
The data were not normally distributed as assessed by the Pearson omnibus test, therefore,
differences were assessed using Mann Whitney U-
calculated to determine the strength of relationships. Statistical analysis was performed
using R software (version 3.1.1, R Foundation for Statistical Computing, Vienna, Austria).
5. RESULTS
Eighteen subjects with a median age of 14.2 (range 6.6-18.5) years were assessed, seven
were female. Their median haemoglobin was 10.1 (range 8.2 11.6) g/dl and the median
packed red cell volume (PRCV)  administered was 500 (250 800) ml.  Eight children
(44%) had had at least one acute chest syndrome episode and four (22%) had a physic
diagnosis of asthma.
Prior to transfusion, their median TLC was 92.2 (71.6-135.1) % predicted for height, RV was
90.1 (61.7-104.3) % predicted for height and RV:TLC was 105.1 (87.4-134.8) % predicted for
height. Six children had an obstructive (33%) and two (11%) a restrictive defect. Pulmonary
capillary blood volume (Figure 1), Rrs5 (Figure 1), Rrs20, R5-R20, Xrs5, AX, DLCO and
KCO all increased after transfusion (p<0.0001, p<0.0001, p = 0.0332, p=0.0082, p=0.0023,
p=0.0052, p<0.0001, p<0.0001, respectively) (Table 1), whereas FEV1, VC, and FEF25-75 all
declined (p=0.0056, p=0.0008, p=0.0483 respectively) (Table1). No significant change was
seen in fres (p=0.0665) or FEV1/VC (p=0.2462). The percentage change from baseline in
pulmonary capillary blood volume correlated with the change in Rrs5 (r=0.50, p=0.04933),
Rrs20 (r=0.60 , p=0.0091) and KCO (r=0.58, p=0.0265), but not with R5-R20 (r= 0.34,
p=0.1612), FEV1 (r=-0.33, p=0.0881), VC (r= - 0.37, p=0.1279), FEF25-75 (r=0.24, p=0.0336),
FEV1/VC (r=0.24, p=0.3280) or DLCO (r=0.31, p=0.1879). The change in pulmonary capillary
blood volume was correlated with the PRCV (r=0.56, p=0.0152).
6. DISCUSSION
We have demonstrated significant changes in lung function immediately following blood
transfusion in children with SCD, increases in respiratory system resistance, reactance and
gas transfer with decreases in FEV1 and VC. Pulmonary capillary blood volume increased
significantly and this change was correlated with changes in Rrs5, Rrs20 and KCO. VC also
decreased, resulting in no significant change in FEV1/VC.
Compared to healthy controls, children with SCD have an elevated cardiac output and
pulmonary blood flow at rest, as well as raised pulmonary capillary blood volume as a result
of chronic anaemia (Chaudry et al 2014, Wedderburn et al 2014).  Our results suggest a
link between increased pulmonary vascular volume and lung function abnormalities in SCD
and that it is possible that respiratory symptoms reported in some children with SCD may
have been incorrectly attributed to asthma. It is important to emphasize that these results
are not highlighting blood transfusions are inappropriate for SCD children, indeed the blood
transfusions were associated with an increase in DLCO and KCO indicating improved gas
exchange. Investigating lung function and capillary blood volume before and after blood
transfusion has given a further means of investigating the association of respiratory
mechanics, lung function abnormalities and pulmonary capillary blood volume.
This study has strengths and some limitations. The main strength of this study was the use
of routine transfusion as a means of fluid loading (a treatment likely to alter pulmonary blood
function to be assessed
at different pulmonary capillary blood volumes, which would be inappropriate to do by other
methods in SCD children and provided evidence of a possible relationship between elevated
pulmonary capillary blood volume and lung function abnormalities. It is important to point out
that the SCD children were in steady state and the impact of a transfusion may be different
in an acutely unwell child with a sickle related episode. We measured the respiratory
system resistance at 5Hz which is better able to capture total resistance to airflow, including
changes in small airway function, than spirometry (Goldman et al 2005). These data were
supported by the respiratory system resistance at 20Hz and frequency dependence of
resistance, all of which increased significantly after transfusion. The low-frequency
respiratory reactance parameters Xrs5 and AX also increased significantly, these
parameters are thought at least in part to assess the elastic properties of the distal lung
(Goldman et al 2005), it is, therefore, possible that the changes we observed related to
changes in pulmonary compliance. The children who participated in the study were all
undergoing regular transfusions as part of their clinical management. Such children are
likely to suffer from more severe disease and may, therefore, be at greater risk of SCD-
related vasculopathy (De Castro et al 2008, Duke et al 1964), which may have modulated
their response to fluid loading.  It would, however, be inappropriate to administer a fluid load
to an unselected cohort of SCD children. Post-transfusion haemoglobin levels were not
available as the haemoglobin concentration takes approximately 24 hours to stabilise after
transfusion. It was not possible, therefore, to correct the post-transfusion DLCO and KCO
measurement for the haemoglobin level and so the uncorrected measurements were used.
Caution must, therefore, be exercised in interpreting those results.   A further limitation in
the interpretation of our data is the lack of a control group, but it would not be appropriate to
administer blood transfusions or intravenous fluids to healthy children. The respiratory
system resistance and reactance results were related to reference ranges derived from
Caucasian subjects (Nowowiejska et al 2008), but since the same reference range was used
for both pre- and post-transfusion measurements, paired comparisons between them were
valid.
7. CONCLUSIONS
In conclusion, this study has demonstrated that significant increases in pulmonary capillary
blood volume and respiratory system resistance occur immediately following blood
transfusion in children with SCD. Furthermore, the increase in respiratory system resistance
significantly correlated with the increase in pulmonary capillary blood volume. These results
provide evidence for a potential interaction between the increased pulmonary capillary blood
volume and pulmonary function abnormalities seen in SCD children.
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